よむ、つかう、まなぶ。
【参考1】診療の手引き・第9.0版 (23 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00416.html |
出典情報 | 「新型コロナウイルス感染症に係る予防接種の実施に関する手引き」の改訂について(2/10付 事務連絡)《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症(COVID-19) 診療の手引き・第 9.0 版 ●2 臨床像
・Saurabh R, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Takazono T, et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese
Respiratory Society. ERJ Open Res 2021.
・Wichmann D, et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med
2020.
・Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.
5. 小児例の特徴
・厚労省事務連絡.新型コロナウイルス感染症の発生に伴う定期の予防接種の実施に係る対応について.2020.3.19.
・国立感染症研究所.新型コロナウイルス感染後の 20 歳未満の死亡例に関する積極的疫学調査(第二報).2022.12.28.
・日本小児科学会.新型コロナウイルス感染症流行時における小児への予防接種について 2020(2020.10.27)
.
・日本小児科学会.予防接種・感染症対策委員会「データベースを用いた国内発症小児 Coronavirus Disease 2019
(COVID-19) 症例の臨床経過に関する検討」に基づく早期公開情報」https://www.coreregistry.jp/CoreRegistry_
COVID19_CRF_ Dashboard/Home/DashBoardviewer
・Aizawa Y, et al. Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
Vaccine 2021.
・Bellino S, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics 2020.
・Butt AA, et al. COVID-19 disease severity in children infected with the Omicron variant. Clin Infect Dis 2022.
・Covid Data Tracker Weekly Review,Interpretive Summary for January 7,2022.
・Mi SH, et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19,Seoul. Emerg
Infect Dis 2020.
・Miller E, et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and
adults in England. J Infect 2021.
・Shoji K, et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after
the emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Shoji K, et al. Clinical characteristics of hospitalized COVID-19 in children: report from the COVID-19 registry in
Japan. J Pediatric Infect Dis Soc 2021.
・Tsankov BK, et al. Severe COVID-19 infection and pediatric comorbidities: A systematic review and metaanalysis. Int J Infect Dis 2021.
・Woodruff RC, et al. Risk factors for severe COVID-19 in children. Pediatrics 2021.
6. 妊婦例の特徴
・日本産婦人科感染症学会・日本産科婦人科学会.COVID-19 ワクチン接種を考慮する妊婦さんならびに妊娠を希望する方へ;
第 2 版.2021.5.12.
・日本産科婦人科学会周産期委員会・周産期における感染に関する小委員会.妊婦の新型コロナウイルスワクチン接種に関す
る WEB アンケート調査結果について.2022.1.12.
・出口雅士,山田秀人.日本における COVID-19 妊婦の現状 ~妊婦レジストリの解析結果(2022 年 5 月 5 日迄の登録症例).
2022.6.7.
・Allotey J, et al. Clinical manifestations,risk factors,and maternal and perinatal outcomes of coronavirus disease
2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020.
・Engjom H, et al. Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women-time for
policies to change. Lancet Reg Health Eur 2022.
・Goldshtein I, et al. Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early
infant outcomes. JAMA Pediatr 2022.
・Halasa NB, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med 2022.
・Hayakawa S, et al. Covid-19 pandemic and pregnancy. J Obstet Gynaecol Res 2020.
・Hayakawa S, et al. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res
2021.
・Komine-Aizawa S, et al. Placental barrier against COVID-19. Placenta 2020.
・Wei SQ, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ
2021.
・Zambrano LD, et al. Update: Characteristics of symptomatic women of reproductive age with laboratoryconfirmed SARS-CoV-2 infection by pregnancy status — United States,January 22–October 3,2020. MMWR
2020.
・Shoji K, et al. Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched
analysis of the data from the COVID-19 Registry Japan. Clin Infect Dis 2022.
・Wadman M. Studies reveal dangers of SARS-CoV-2 infection in pregnancy. Science 2022.
7. 罹患後症状
・新型コロナウイルス感染症診療の手引き 別冊:罹患後症状のマネジメント 第 2 版.2022.10.14.
・Morioka S, et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J Infect Chemother 2022.
・Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis
2022.
◀︎ CONTENTS
23
・Saurabh R, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Takazono T, et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese
Respiratory Society. ERJ Open Res 2021.
・Wichmann D, et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med
2020.
・Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.
5. 小児例の特徴
・厚労省事務連絡.新型コロナウイルス感染症の発生に伴う定期の予防接種の実施に係る対応について.2020.3.19.
・国立感染症研究所.新型コロナウイルス感染後の 20 歳未満の死亡例に関する積極的疫学調査(第二報).2022.12.28.
・日本小児科学会.新型コロナウイルス感染症流行時における小児への予防接種について 2020(2020.10.27)
.
・日本小児科学会.予防接種・感染症対策委員会「データベースを用いた国内発症小児 Coronavirus Disease 2019
(COVID-19) 症例の臨床経過に関する検討」に基づく早期公開情報」https://www.coreregistry.jp/CoreRegistry_
COVID19_CRF_ Dashboard/Home/DashBoardviewer
・Aizawa Y, et al. Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
Vaccine 2021.
・Bellino S, et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics 2020.
・Butt AA, et al. COVID-19 disease severity in children infected with the Omicron variant. Clin Infect Dis 2022.
・Covid Data Tracker Weekly Review,Interpretive Summary for January 7,2022.
・Mi SH, et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19,Seoul. Emerg
Infect Dis 2020.
・Miller E, et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and
adults in England. J Infect 2021.
・Shoji K, et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after
the emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Shoji K, et al. Clinical characteristics of hospitalized COVID-19 in children: report from the COVID-19 registry in
Japan. J Pediatric Infect Dis Soc 2021.
・Tsankov BK, et al. Severe COVID-19 infection and pediatric comorbidities: A systematic review and metaanalysis. Int J Infect Dis 2021.
・Woodruff RC, et al. Risk factors for severe COVID-19 in children. Pediatrics 2021.
6. 妊婦例の特徴
・日本産婦人科感染症学会・日本産科婦人科学会.COVID-19 ワクチン接種を考慮する妊婦さんならびに妊娠を希望する方へ;
第 2 版.2021.5.12.
・日本産科婦人科学会周産期委員会・周産期における感染に関する小委員会.妊婦の新型コロナウイルスワクチン接種に関す
る WEB アンケート調査結果について.2022.1.12.
・出口雅士,山田秀人.日本における COVID-19 妊婦の現状 ~妊婦レジストリの解析結果(2022 年 5 月 5 日迄の登録症例).
2022.6.7.
・Allotey J, et al. Clinical manifestations,risk factors,and maternal and perinatal outcomes of coronavirus disease
2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020.
・Engjom H, et al. Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women-time for
policies to change. Lancet Reg Health Eur 2022.
・Goldshtein I, et al. Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early
infant outcomes. JAMA Pediatr 2022.
・Halasa NB, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med 2022.
・Hayakawa S, et al. Covid-19 pandemic and pregnancy. J Obstet Gynaecol Res 2020.
・Hayakawa S, et al. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res
2021.
・Komine-Aizawa S, et al. Placental barrier against COVID-19. Placenta 2020.
・Wei SQ, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ
2021.
・Zambrano LD, et al. Update: Characteristics of symptomatic women of reproductive age with laboratoryconfirmed SARS-CoV-2 infection by pregnancy status — United States,January 22–October 3,2020. MMWR
2020.
・Shoji K, et al. Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched
analysis of the data from the COVID-19 Registry Japan. Clin Infect Dis 2022.
・Wadman M. Studies reveal dangers of SARS-CoV-2 infection in pregnancy. Science 2022.
7. 罹患後症状
・新型コロナウイルス感染症診療の手引き 別冊:罹患後症状のマネジメント 第 2 版.2022.10.14.
・Morioka S, et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J Infect Chemother 2022.
・Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis
2022.
◀︎ CONTENTS
23